Biomark Diagnostics
An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. Learn more
Launch date
Employees
Market cap
CAD22.7m
Enterprise valuation
CAD23m (Public information from Sep 2024)
Share price
CAD0.26 BUX.CN
Richmond British Columbia (HQ)
Authorizing premium user...